Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Jun;5(6):827-42.
doi: 10.1002/emmm.201202301. Epub 2013 May 16.

Systemic ceramide accumulation leads to severe and varied pathological consequences

Abdulfatah M Alayoubi  1 , James C M Wang, Bryan C Y Au, Stéphane Carpentier, Virginie Garcia, Shaalee Dworski, Samah El-Ghamrasni, Kevin N Kirouac, Mathilde J Exertier, Zi Jian Xiong, Gilbert G Privé, Calogera M Simonaro, Josefina Casas, Gemma Fabrias, Edward H Schuchman, Patricia V Turner, Razqallah Hakem, Thierry Levade, Jeffrey A Medin
Affiliations

Systemic ceramide accumulation leads to severe and varied pathological consequences

Abdulfatah M Alayoubi et al. EMBO Mol Med. 2013 Jun.

Abstract

Farber disease (FD) is a severe inherited disorder of lipid metabolism characterized by deficient lysosomal acid ceramidase (ACDase) activity, resulting in ceramide accumulation. Ceramide and metabolites have roles in cell apoptosis and proliferation. We introduced a single-nucleotide mutation identified in human FD patients into the murine Asah1 gene to generate the first model of systemic ACDase deficiency. Homozygous Asah1(P361R/P361R) animals showed ACDase defects, accumulated ceramide, demonstrated FD manifestations and died within 7-13 weeks. Mechanistically, MCP-1 levels were increased and tissues were replete with lipid-laden macrophages. Treatment of neonates with a single injection of human ACDase-encoding lentivector diminished the severity of the disease as highlighted by enhanced growth, decreased ceramide, lessened cellular infiltrations and increased lifespans. This model of ACDase deficiency offers insights into the pathophysiology of FD and the roles of ACDase, ceramide and related sphingolipids in cell signaling and growth, as well as facilitates the development of therapy.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Growth defects, splenomegaly, and premature death of Asah1P361R/P361R mice. General assessment of Asah1P361R/P361R mice

  1. A photograph of 10-week-old wild-type (WT), heterozygous (Het), and Asah1P361R/P361R mice.

  2. Growth curves measured in weights versus age (n = 10 of each genotype). Error bars represent standard errors of the mean.

  3. Kaplan–Meier survival analysis (n = 16 for each genotype).

  4. A photograph of spleens from each genotype.

  5. Ratios of spleen weights to body weights (n = 5 for heterozygous (Het) and Asah1P361R/P361R mice; n = 3 for WT). Bars represent mean values. Error bars represent standard errors of the mean.

  6. Brain MRI scans of 10-week-old WT, heterozygous, and Asah1P361R/P361R littermates. Hydrocephaly was detected in 5 out of 7 Asah1P361R/P361R mice. Arrows indicate dilated brain ventricles.

Figure 2
Figure 2. Impaired development of the ovaries in Asah1P361R/P361R mice

  1. Pictures of ovaries from 9-week-old WT, heterozygous, and Asah1P361R/P361R mice showing size differences.

  2. Analysis of follicular numbers at different stages in 9-week-old WT (n = 2), heterozygous (n = 1), and Asah1P361R/P361R mice (n = 3). This analysis of follicular numbers was done once. Bars represent mean values. Error bars represent standard errors of the mean.

Figure 3
Figure 3. Altered hematopoiesis in Asah1P361R/P361R mice

  1. A,B. Blood samples were collected from all animals at 7–10 weeks. Total leukocyte, monocyte, neutrophil, and eosinophil counts were determined (A); and (B) erythrocytes and hemoglobin levels were measured in WT (n = 10), heterozygous (n = 7), and Asah1P361R/P361R mice (n = 9). The cell counts were measured once. Bars represent mean values. Error bars represent standard errors of the mean.

Figure 4
Figure 4. Accumulation of ceramide and reduction of ACDase activity in various tissues of Asah1P361R/P361R mice

  1. Samples from spleens, livers, brains, lungs, hearts, and kidneys of 7- to 10-week-old mice were analyzed for total ceramide using an E. coli DAG kinase assay (n = 2 for all genotypes). The data points represent the average values from two independent experiments. Bars represent mean values. Error bars represent standard errors of the mean.

  2. Samples from livers, hearts, spleens, thymuses, and brains of 7- to 10-week-old mice were analyzed for ACDase activity by a liposome-based TLC assay using C12-NBD-Ceramide as the substrate at pH 4.6 (n = 3). This experiment was done once. Bars represent mean values. Error bars represent standard errors of the mean.

Figure 5
Figure 5. Infiltrating macrophages and pathognomonic Farber bodies in Asah1P361R/P361R mice

  1. H&E staining of liver, spleen, thymus, and sciatic nerve of 7- to 10-week-old mice (arrow indicates infiltrating macrophages).

  2. Safranin-O staining of femurs from 7-week-old mice shows thinner epiphyseal growth plates in Asah1P361R/P361R mice compared to a WT littermate (arrows).

  3. Electron microscopy images of hepatic (left panel) and peripheral nerve (right panel) sections from Asah1P361R/P361R mice. Arrows indicate Farber bodies.

Figure 6
Figure 6. Increased levels of MCP-1 in Asah1P361R/P361R mice

  1. Serum cytokine levels in WT (n = 3), heterozygotes (n = 5), and Asah1P361R/P361R mice (n = 5). The levels of serum cytokines were measured once. Bars represent mean values. Error bars represent standard errors of the mean.

  2. MCP-1 levels in lysates from livers, brains, spleens, and thymuses of Asah1P361R/P361R and WT mice (n = 4). The tissue MCP-1 levels were measured once. Bars represent mean values. Error bars represent standard errors of the mean.

Figure 7
Figure 7. Improved growth curves and survival in Asah1P361R/P361R mice treated as neonates with a recombinant LV engineering expression of human ACDase

  1. A representative picture of 10-week-old LV/enGFP-WT, LV/enGFP-Asah1P361R/P361R, and LV/ACDase-Asah1P361R/P361R mice.

  2. Growth curves measured in weights versus age for: LV/enGFP-WT (n = 8); LV/ACDase-WT (n = 7); LV/enGFP-Het and LV/ACDase-Het (n = 10); LV/enGFP-Asah1P361R/P361R (n = 8); and LV/ACDase-Asah1P361R/P361R (n = 7). Error bars represent standard errors of the mean.

  3. Kaplan-Meier survival analysis for all treated genotypes: LV/enGFP-WT (n = 8); LV/ACDase-WT (n = 8); LV/enGFP-Het (16); LV/ACDase-Het (n = 34); LV/enGFP-Asah1P361R/P361R (n = 8); and LV/ACDase-Asah1P361R/P361R (n = 9).

Figure 8
Figure 8. Reduced leukocyte counts in Asah1P361R/P361R mice after LV/ACDase treatment
Blood samples were collected from all animals at 10–12 weeks. Total leukocytes and differential counts were analyzed in control and experimental genotype groups: LV/enGFP-WT (n = 8); LV/ACDase-WT (n = 7); LV/enGFP-Het (n = 8); LV/ACDase-Het (n = 8); LV/enGFP-Asah1P361R/P361R (n = 7); and LV/ACDase-Asah1P361R/P361R (n = 9). The cell counts were measured once. Bars represent mean values. Error bars represent standard errors of the mean.
Figure 9
Figure 9. Decreased ceramide levels and diminished macrophage infiltrations in Asah1P361R/P361R mice after LV/ACDase treatment

  1. Samples from spleens, livers, and brains of 10-week-old LV/enGFP-WT, LV/ACDase-WT, LV/enGFP-Asah1P361R/P361R, and LV/ACDase-Asah1P361R/P361R mice, and 14- to 16-week-old LV/ACDase-Asah1P361R/P361R mice were analyzed for total ceramide using mass spectrometry (n = 2 for all groups). The data points represent average values from two independent experiments. Bars represent mean values. Error bars represent standard errors of the mean.

  2. H&E staining of spleen and liver from 10-week-old LV/enGFP-WT, LV/enGFP-Asah1P361R/P361R, and LV/ACDase-Asah1P361R/P361R mice (arrows indicate foamy macrophages).

See this image and copyright information in PMC

Comment in

References

    1. Amarnath S, Mangus CW, Wang JC, Wei F, He A, Kapoor V, Foley JE, Massey PR, Felizardo TC, Riley JL, et al. The PDL1-PD1 axis converts human TH1 cells into regulatory T cells. Sci Transl Med. 2011;3:111ra120. - PMC - PubMed
    1. Antonarakis SE, Valle D, Moser HW, Moser A, Qualman SJ, Zinkham WH. Phenotypic variability in siblings with Farber disease. J Pediatr. 1984;104:406–409. - PubMed
    1. Bar J, Linke T, Ferlinz K, Neumann U, Schuchman EH, Sandhoff K. Molecular analysis of acid ceramidase deficiency in patients with Farber disease. Hum Mutat. 2001;17:199–209. - PubMed
    1. Beckham TH, Lu P, Cheng JC, Zhao D, Turner LS, Zhang X, Hoffman S, Armeson KE, Liu A, Marrison T, et al. Acid ceramidase-mediated production of sphingosine 1-phosphate promotes prostate cancer invasion through upregulation of cathepsin B. Int J Cancer. 2012;131:2034–2043. - PMC - PubMed
    1. Bielawska A, Perry DK, Hannun YA. Determination of ceramides and diglycerides by the diglyceride kinase assay. Anal Biochem. 2001;298:141–150. - PubMed

Publication types

MeSH terms